It has been suggested that LEAP2 is regulated in a manner diametrically opposite to that of ghrelin, and that increased levels of LEAP2 in the state of obesity contributes to ghrelin resistance [114]. Here, LEAP2 is linked to obesity due to melanocortin 4 receptor deficiency.